Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Scott Wright

Showing results (81-90 of 158) with videos related to

Pageof 16
Sort By:
Atherosclerosis|November 28, 2023
Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trialsUlf Landmesser, Wolfgang Koenig, Lawrence A Leiter, et al.
European Journal of Preventive Cardiology|April 17, 2025
Efficacy and safety of inclisiran based on background lipid-lowering treatmentUlf Landmesser, Wolfgang Koenig, Lawrence A Leiter, et al.
American Journal of Hypertension|October 10, 2025
High-Intensity Atorvastatin and 24-Hour Blood Pressure in Obstructive Sleep Apnea: A Randomized, Double-Blind, Placebo-Controlled Pilot StudyJoshua M Bock, Soumya Vungarala, Sreeja Sompalli, et al.
Cardiovascular Drugs and Therapy|December 22, 2022
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled TrialsWolfgang Koenig, Lorena Garcia Conde, Ulf Landmesser, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 17, 2012
Chronic kidney disease as a risk factor for acute coronary syndromes in patients presenting to the emergency room with chest painSherezade Khambatta, Michael E Farkouh, R Scott Wright, et al.
Journal of the American Society of Nephrology : JASN|January 28, 2026
Inclisiran in Patients with CKD: Post Hoc Pooled Analysis of Three Phase 3 TrialsUlf Landmesser, Kausik K Ray, Frederick J Raal, et al.
Journal of the American College of Cardiology|March 12, 2004
Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarctionGraham S Hillis, Jacob E Møller, Patricia A Pellikka, et al.
Elife|June 4, 2021
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortalityArturo Casadevall, Quigly Dragotakes, Patrick W Johnson, et al.
American Journal of Preventive Cardiology|May 30, 2023
Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11Wolfgang Koenig, Kausik K Ray, Ulf Landmesser, et al.
Clinical Cardiology|January 26, 2002
Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectorisRyan V Cantwell, Ronnier J Aviles, Johannes Bjornsson, et al.
Pageof 16

Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Atherosclerosis|November 28, 2023
Inclisiran in patients with prior myocardial infarction: A post hoc pooled analysis of the ORION-10 and ORION-11 Phase 3 randomised trialsUlf Landmesser, Wolfgang Koenig, Lawrence A Leiter, et al.
European Journal of Preventive Cardiology|April 17, 2025
Efficacy and safety of inclisiran based on background lipid-lowering treatmentUlf Landmesser, Wolfgang Koenig, Lawrence A Leiter, et al.
American Journal of Hypertension|October 10, 2025
High-Intensity Atorvastatin and 24-Hour Blood Pressure in Obstructive Sleep Apnea: A Randomized, Double-Blind, Placebo-Controlled Pilot StudyJoshua M Bock, Soumya Vungarala, Sreeja Sompalli, et al.
Cardiovascular Drugs and Therapy|December 22, 2022
Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled TrialsWolfgang Koenig, Lorena Garcia Conde, Ulf Landmesser, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 17, 2012
Chronic kidney disease as a risk factor for acute coronary syndromes in patients presenting to the emergency room with chest painSherezade Khambatta, Michael E Farkouh, R Scott Wright, et al.
Journal of the American Society of Nephrology : JASN|January 28, 2026
Inclisiran in Patients with CKD: Post Hoc Pooled Analysis of Three Phase 3 TrialsUlf Landmesser, Kausik K Ray, Frederick J Raal, et al.
Journal of the American College of Cardiology|March 12, 2004
Noninvasive estimation of left ventricular filling pressure by E/e' is a powerful predictor of survival after acute myocardial infarctionGraham S Hillis, Jacob E Møller, Patricia A Pellikka, et al.
Elife|June 4, 2021
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortalityArturo Casadevall, Quigly Dragotakes, Patrick W Johnson, et al.
American Journal of Preventive Cardiology|May 30, 2023
Efficacy and safety of inclisiran in patients with cerebrovascular disease: ORION-9, ORION-10, and ORION-11Wolfgang Koenig, Kausik K Ray, Ulf Landmesser, et al.
Clinical Cardiology|January 26, 2002
Cardiac amyloidosis presenting with elevations of cardiac troponin I and angina pectorisRyan V Cantwell, Ronnier J Aviles, Johannes Bjornsson, et al.
Pageof 16